World-Leading Microsurgeon Professor J.P. Hong Joins MediThinQ as CMO, Marking Strong Validation for Next-Generation Digital Microsurgery

by | PRNewswire Asia

SINGAPORE, Dec. 3, 2025 /PRNewswire/ — MediThinQ, a fast-growing innovator in surgical displays and digital 3D microscopy, today announced that world-renowned reconstructive microsurgeon Prof. Joon-pio Hong has joined the company as Chief Medical Officer....

Celltrion announces U.S. FDA approval of 300mg strength of OMLYCLO® (omalizumab-igec), the first and only FDA-approved interchangeable biosimilar to XOLAIR®

by | PRNewswire Asia

FDA approval of OMLYCLO® (omalizumab-igec) 300 mg/2 mL solution in a single-dose prefilled syringe for subcutaneous injection expands dosing flexibility and supports tailored treatment for individual patients with certain allergic diseases OMLYCLO®...

"Marishi Fuji" Wins Grand Gold Prize at the World Green Tea Contest 2025

by | PRNewswire Asia

LOS ANGELES, Dec. 2, 2025 /PRNewswire/ — Phenimax, a specialty tea retailer devoted to premium organic Japanese teas, is proud to announce a significant achievement. Its flagship organic Temomicha (Hand-rolled Japanese Tea), "Marishi Fuji," has...

Lunit to Highlight New AI Evidence in Cancer Screening and Breast Density-Driven Risk Modeling at RSNA 2025

by | PRNewswire Asia

Eight oral presentations and six posters demonstrate advances in mammography, DBT performance, and density-informed risk modeling SEOUL, South Korea, Dec. 2, 2025 /PRNewswire/ — Lunit, a leading provider of AI for cancer diagnostics and precision oncology, today...

Yuyu Pharma Announces Strategic Investment in Dalan Animal Health as Part of Accelerated Global Expansion in Animal Health

by | PRNewswire Asia

SEOUL, South Korea, Dec. 2, 2025 /PRNewswire/ — Yuyu Pharma announced today that it has completed a strategic investment in Dalan Animal Health, a U.S.-based biotechnology company advancing an innate immunity–based platform for developing vaccines for honeybees...

L&C Bio's 'Re2O' Emerges as a Leading K-Medical Tour Procedure Within One Year of Launch

by | PRNewswire Asia

– Surging global demand drives rapid adoption across domestic and international medical sectors – SEONGNAM, South Korea, Dec. 2, 2025 /PRNewswire/ — L&C Bio (KOSDAQ: 290650, Co-CEOs Hwan-Chul Lee and Jae-Ho Lee), a leading company in human tissue–based...